Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

Press Releases

All Releases
View Summary Study Demonstrates OPKO's 4Kscore Test Reduces Unnecessary Prostate Biopsies While Improving Risk Prediction for Aggressive Prostate Cancer
Feb 9, 2016
PDF 67.5 KB
View Summary OPKO's GeneDx to Present at Personalized Medicine World Conference
Jan 22, 2016
PDF 15.7 KB
View Summary OPKO Health to Present at the J.P. Morgan 34th Annual Healthcare Conference
Jan 6, 2016
PDF 11.6 KB
View Summary Conversion Right Extended on OPKO 3.0% Convertible Senior Notes
Jan 5, 2016
PDF 11.5 KB
View Summary OPKO's GeneDx Study of More Than 10,000 Individuals Tested with Multigene NGS Hereditary Cancer Panel Reveals New Risks
Dec 21, 2015
PDF 15.9 KB
View Summary OPKO's GeneDx Subsidiary and North Shore-LIJ Health System Form Strategic Alliance for Genetic Testing
Dec 14, 2015
PDF 20.4 KB
View Summary OPKO's GeneDx Study Demonstrates Whole Exome Sequencing Usefulness In Diagnosing Rare Disorders
Dec 9, 2015
PDF 13.1 KB
View Summary OPKO Health to Present at the Oppenheimer 26th Annual Healthcare Conference
Dec 2, 2015
PDF 11.4 KB
View Summary OPKO Health to Present at the Jefferies Autumn 2015 Global Healthcare Conference
Nov 17, 2015
PDF 11.3 KB
View Summary OPKO Licensee TESARO Announces the Launch of VARUBI(TM) (Rolapitant) in the United States
Nov 16, 2015
PDF 69.7 KB
View Summary OPKO 4Kscore Test Receives Category I CPT Code Approval
Nov 12, 2015
PDF 15.1 KB
View Summary OPKO Announces Third Quarter Financial and Operating Results
Nov 9, 2015
PDF 31.6 KB
View Summary OPKO Health Refinances Bio-Reference Laboratories Credit Facility
Nov 6, 2015
PDF 13.7 KB
View Summary OPKO to Announce Third Quarter Operating and Financial Results on November 9, 2015
Nov 5, 2015
PDF 13.2 KB
View Summary Additional Phase 3 Data Supporting OPKO's Rayaldee as a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at Kidney Week 2015
Nov 5, 2015
PDF 16.1 KB
View Summary OPKO Health Expands Portfolio of Tests for Inherited Forms of Cancer
Oct 22, 2015
PDF 13.3 KB
View Summary OPKO Health's GeneDx business Presenting at National Society of Genetic Counselors Annual Meeting
Oct 21, 2015
PDF 104.1 KB
View Summary Vanderbilt University School of Medicine and OPKO Health Collaborate on Genomics
Oct 13, 2015
PDF 13.7 KB
View Summary OPKO to Host Symposium to Present Clinical Data on its Long-acting Human Growth Hormone at the 49th Annual Meeting of the Japanese Society for Pediatric Endocrinology
Oct 8, 2015
PDF 12.0 KB
View Summary OPKO Presents Clinical Data on its Long-acting Human Growth Hormone (hGH-CTP) in Two Oral Presentations at the 54th Annual Meeting of the European Society for Pediatric Endocrinology (ESPE)
Oct 7, 2015
PDF 14.3 KB
Showing 1-20 of 258 Page: 1 2 3 4 5 ... 13  Next 20

Email  Sign up for email alerts